Dr. Alexis Finlay reports her Ridgefield ophthalmology practice is among the first sites in the area to perform an innovative laser treatment to reduce intraocular pressure (IOP), the No. 1 risk factor for glaucoma.
IOP is caused by a buildup of fluid in the eyes and can lead to glaucoma. Glaucoma is a degenerative disease that can cause a slow loss of vision and even blindness without warning.
“Vision loss is often the first, irreversible symptom of glaucoma,” Dr. Finlay said. “Glaucoma affects more than 3 million Americans. Because glaucoma is a progressive disease, proper diagnosis and long-term management is critical to prevent further loss of vision or blindness.”
SLT (selective laser trabeculoplasty) therapy has been proven safe, effective and durable in clinical studies, she said. “Thousands of SLT treatments have been successfully performed.” Dr. Finlay said it provides “a safe and proven alternative to daily eye drop medications, which can be costly and are often associated with unwanted side effects.
“Most patients recently treated with SLT therapy at Ridgefield Eye Physicians have experienced a significant decrease in IOP, and reduced or eliminated their need to take daily eye drop medications,” she said.
“Patients have been very happy with the SLT laser therapy,” said Dr. Finlay. “I’ve seen significant reductions in their intraocular pressure, often allowing them to decrease or even eliminate the need for topical glaucoma medications. And since this is a Medicare-covered procedure, my patients may save money if we can reduce their need for glaucoma medications. Most importantly, vision is protected.”
Until now, she added, “treatment options included topical glaucoma medication or more invasive surgery. Some of these treatments may compromise quality of life, increase out-of-pocket expenses or cause undesirable side effects.”
Dr. Finlay is located at 38 B Grove Street. Call 203-403-3375 for more information.